Showing results (1911-1920 of 2,169) with videos related to

Sort By:
Pageof 217
Expert Opinion on Biological Therapy|June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 yearMarco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
Annals of the American Thoracic Society|February 25, 2021
Defining Resilience to Smoking-related Lung Disease: A Modified Delphi Approach from SPIROMICSAnita L Oh, Richard A Mularski, Igor Barjaktarevic, et al.
Nature Communications|June 15, 2026
Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faeciumKyong T Fam, Pavan Kumar Chodisetti, Zifei Wang, et al.
Gastrointestinal Endoscopy|December 30, 2019
Prospective multicenter study to evaluate capsule endoscopy competency using a validated assessment toolElizabeth Rajan, Manuel Martinez, Emmanuel Gorospe, et al.
BMC Medical Genetics|August 3, 2018
Genome-wide association study of lung function and clinical implication in heavy smokersXingnan Li, Victor E Ortega, Elizabeth J Ampleford, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2022
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort StudyRussell G Buhr, Igor Z Barjaktarevic, P Miguel Quibrera, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 29, 2020
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS CohortMarni Stott-Miller, Hana Müllerová, Bruce Miller, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2021
Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations In Vivo: A Clinical TrialJaideep Dhariwal, Aoife Cameron, Ernie Wong, et al.
Annals of the American Thoracic Society|April 3, 2024
Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary DiseaseNicolas A Baddour, Laura M Paulin, Amanda J Gassett, et al.
Addiction (Abingdon, England)|February 7, 2022
HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trialP Todd Korthuis, Ryan R Cook, Paula J Lum, et al.
Pageof 217